Factor VII/VIIa: A new antigen in the anti-phospholipid antibody syndrome

British Journal of Haematology

Volumn 120, Issue 4, 2003, Pages 618-626

  Bidot, Carlos J ^a   Jy, Wenche ^a   Horstman, Lawrence L ^a   Huisheng, Huang ^a   Jimenez, Joaquin J ^a   Yaniz, Miriam ^a   Ahn, Yeon S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Anti phospholipid syndrome (APS); Beta 2 glycoprotein 1; Cardiolipin; Factor VII VIIa; Target antigens; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; CARDIOLIPIN; CLOPIDOGREL; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; WARFARIN;

ADULT; AGED; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INCIDENCE; MALE; PRIORITY JOURNAL; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; AUTOANTIGENS; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; FACTOR VII; FACTOR VIIA; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; THROMBOSIS; VENOUS THROMBOSIS;

EID: 0037327770     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04161.x     Document Type: Article

References (64)

1. Alving, B.M. (1998) Antiphospholipid syndrome, lupus anticoagulants, and anticardiolipin antibodies. In: Thrombosis and Hemorrhage. 2nd edn (ed. by J. Loscalzo & A.I. Schafer), Chap. 38, pp. 817-836. Williams & Wilkins, Baltimore.
2. Amengual, O., Atsumi, T., Khamashta, M.A., Koike, T. & Hughes, G.R.V. (1996) Specificity of ELISA for antibody to β2-glycoprotein 1 in patients with antiphospholipid syndrome. British Journal of Rheumatology, 35, 1239-1243.
3. Amiral, J., Larrivaz, I., Cluzeau, D. & Adam, M. (1994) Standardization of immunoassays for antiphospholipid antibodies with β2GP1 and role of other phospholipid cofactors. Haemostasis, 24, 191-203.
4. Arnout, J. (2001) Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants. Thrombosis and Haemostasis, 86, 83-91.
5. Arnout, J., Wittevrongel, C., Vanrusselt, M., Hoylaerts, M. & Vermylen, J. (1998) Beta-2-glycoprotein 1 dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein 1 complexes on phospholipid surfaces. Thrombosis and Haemostasis, 79, 79-86.
6. Bajaj, M.S., Birktoft, J.S., Steer, S.A. & Bajaj, S.P. (2001) Structure and biology of tissue factor pathway inhibitor. Thrombosis and Haemostasis, 86, 959-972.
7. Bladbjerg, E.M., Loller, L. & Jespersen, J. (1998) Is factor VII protein concentration (FVII:Ag) a thrombotic risk indicator? Thrombosis and Haemostasis, 79, 1064-1065.
8. Branch, D.W. & Rodgers, G.M. (1993) Induction of endothelial tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. American Journal of Obstetrics and Gynecology, 168, 206-210.
9. Camerer, E., Kolsta, A.B. & Prydz, H. (1996) Cell biology of tissue factor, the principal initiator of blood coagulation. Thrombosis Research, 81, 1-41.
10. Campbell, E., Sanal, S., Mattson, J., Walker, L., Estry, S., Mueller, L., Schwarz, M. & Hampton, S. (1980) Factor VII inhibitor. American Journal of Medicine, 68, 962-964.
11. Cunningham, M.A., Romas, P., Hutchinson, P., Holdsworth, S.R. & Tipping, P.G. (1999) Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood, 94, 3413-3420.
12. D'Angelo, A., Safa, O., Crippa, L., Garlando, A., Sabbadini, M.G. & D'Angelo, S.V. (1997) Relationship of lupus anticoagulant, anticardiolipin, anti-beta-2-GP1 and anti-prothrombin autoantibodies with history of thrombosis in patients with the clinical suspicion of APA syndrome (letter). Thrombosis and Haemostasis, 78, 967-968.
13. Delmer, A., Horellou, M.H., Andreu, G., Lecompte, T., Rossi, F., Kazatchkine, M.D., Samama, M. & Zittoun, R. (1989) Life-threatening intracranial bleeding associated with the presence of an antifactor VII autoantibody. Blood, 74, 229-232.
14. Donohoe, S., Mackie, I.J., Isenberg, D. & Machin, S.J. (2001) Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome. British Journal of Haematology, 113, 544-549.
15. Drouvalakis, K.A. & Buchanan, R.R. (1998) Phospholipid specificity of autoimmune and drug induced lupus anticoagulants: association of phosphatidylethanolarrfine reactivated thrombosis in autoimmune disease. Journal of Rheumatology, 25, 290-295.
16. Eriksson-Berg, M., Silveira, A., Orth-Gomer, K., Anders, H. & Schenk-Gustafsson, K. (2001) Coagulation factor VII in middle aged women with and without coronary heart disease. Thrombosis and Haemostasis, 85, 787-792.
17. Escoffre, M., Zini, J.M., Schliamser, L., Mazoyer, E., Soria, C., Tobalem, G. & Dupuy, E. (1995) Severe arterial thrombosis in a congenitally factor VII deficient patient. British Journal of Haematology. 91, 739-741.
18. Espinola, R.G., Liu, X., Stanfield, M.C., Harris, E.N. & Pierangeli, S.S. (2001) Effects of antiphospholipid antibodies on thrombosis and endothelial cell activation are mediated by E-selectin. Blood, 98, 49a (abstract 197).
19. Forastiero, R., Martinuzzo, M., Carreras, L.O. & Maclouf, J. (1998) Anti-β2 glycoprotein 1 antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites. Thrombosis and Haemostasis, 79, 42-45.
20. Galli, M. & Barbui, T. (1999) Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. Blood, 93, 2149-2157.
21. Galli, M., Finazzi, G. & Barbui, T. (1997) Antiphospholipid antibodies: predictive value of laboratory tests. Thrombosis and Haemostasis, 78, 75-78.
22. Galli, M., Dlott, J., Norbis, F., Ruggeri, L., Clef, L., Triplett, D.A. & Barbui, T. (2000) Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests. Thrombosis and Haemostasis, 84, 1012-1016.
23. Gilman-Sachs, A., Lubinski, J., Beer, A.E., Brend, S. & Beaman, K.D. (1991) Patterns of anti-phospholipid antibody specificities. Journal of Laboratory and Clinical Immunology, 35, 83-88.
24. Greaves, M. (1999) Antiphospholipid antibodies and thrombosis. Lancet, 353, 1348-1353.
25. Harris, E.N. (1987) Syndrome of black swan. British Journal of Rheumatology, 26, 324-326.
26. Herbert, J.M., deProst, D., Ollivier, V., Melis, E. & Carmeliet, P. (2001) Tissue factor is not involved in the mitogenic activity of Factor VIIa. Biochemical and Biophysical Research Communications, 281, 1074-1077.
27. Hill, M.B., Phipps, J.L., Hughes, P. & Greaves, M. (1998) Anti-endothelial cell antibodies in primary antiphospholipid syndrome and SLE: patterns of reactivity with membrane antigens on microvascular and umbilical venous cell membranes. British Journal of Haematology, 103, 416-421.
28. Hoefner, D.M. & Yeo, K.T.J. (2002) Lot-to-lot inconsistency of anticardiolipin reagents. Clinical Chemistry, 48, 1625-1626.
29. Horbach, D.A., vanOort, E., Donders, R.C.J.M., Derksen, R.H.W.M. & deGroot, P.G. (1996) Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphosphollpid antibodies. Thrombosis and Haemostasis, 76, 916-924.
30. Horkko, S., Miller, E., Dudl, E., Reaven, P., Curtiss, L.K., Zvaifler, N.J., Terkeltaub, R., Pierangeli, S.D., Branch, D.W., Palinski, W. & Witztum, J.L. (1996) Antiphospholipid antibodies are binding against epitopes of oxidized phospholipids. Journal of Clinical Investigation. 98, 815-825.
31. Horstman, L.L., Jy, W., Bidot, C., Cast, L., Valle, M., Huang, H., Dacas. S.B., Jimenez, J.J. & Ahn, Y.S. (2001) Factor VIIa clot time (FVIIa CT) is more sensitive to lupus anticoagulant (LAC) than a widely used commercial method. Blood, 98, 73b (abstract 3914).
32. Humphries, S.E., Lane, A., Green, F.R., Cooper, J. & Miller, G.J. (1994) Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arteriosclerosis, Thrombosis and Vascular Biology, 14, 193-198.
33. Kamikubo, Y., Miyamoto, S., Iwasa, A., Ishii, M. & Okajima, K. (2000) Purification and characterization of factor VII inhibitor found in a patient with life-threatening bleeding. Thrombosis and Haemostasis, 83, 60-64.
34. Kasper, C.K. (1975) Thromboembolic complications. Thrombosis et Dtathesis Haemorrhagica, 33, 640-644.
35. Lopez, L., Dier, K., Taylor, D., Olsen, L., Fink, C., Levy, V. & Adcock, D. (2001) Comparative sensitivity and specificity of various antiphospholipid antibodies for thrombosis in samples with lupus anticoagulant (ISTH XVIII Meeting). Thrombosis and Haemostasis, Suppl., Abstract P2935.
36. McCrae, K.R., DeMichele, A., Samuels, P., Roth, D., Kuo, A., Meng, Q., Rauch, J. & Cines, D.B. (1991) Detection of endothelial cell-reactive immunoglobulin in patients with antiphospholipid antibodies. British Journal of Haematology, 79, 595-605.
37. McIntyre, J.A., Wagenknecht, D.R. & Sugi, T. (1997) Phospholipid binding plasma proteins required for antiphospholipid antibody detection: an overview. American Journal of Reproductive Immunology, 37, 101-110.
38. Martinuzzo, M.E., Maclouf, J., Carreras, L.O. & Levy-Toledano, S. (1993) Antiphospholipid antibodies enhance thrombin induced platelet activation and thromboxane formation. Thrombosis and Haemostasis, 70, 667-671.
39. Matsuda, J., Gohchi, K. & Kawasugi, K. (1997) Increased factor VIIa levels in systemic lupus erythematosus patients with lupus anticoagulant. International Journal of Hematology, 65, 143-149.
40. Matsuura, E., Igarashi, Y., Yasuda, T., Koike, T., Triplett, D.A. & Koike, T. (1994) Anticardiolipin antibodies recognize β2-glycoprotein 1 structure altered by interacting with an oxygen modified solid phase surface. Journal of Experimental Medicine, 179, 457-462.
41. Meroni, P.L., Raschi, E., Testoni, C., Tincani, A. & Balestrieri, G. (2001) Antiphospholipid antibodies and the endothelium. Rheumatological Disease Clinics of North America, 27(s), 587-602.
42. Miller, G.J., Bauer, K.A., Barzegar, S., Cooper, J.A. & Rosenberg, R.D. (1996) Increased activation of the haemostatic system in men at high risk of fatal coronary artery disease. Thrombosis and Haemostasis, 75, 767-771.
43. Nava, A., Banales, J.L. & Reyes, P.A. (1993) Heat inactivation of bovine serum used for blockade in immunoenzymatic assay is associated with spurious fall on the titers of anticardiolipin antibodies in primary antiphospholipid syndrome sera. Journal of Clinical Laboratory Analysis, 7, 116-118.
44. Ndimbie, O.K., Raman, B.K.S. & Saeed, S.M. (1989) Lupus anticoagulant associated with specific inhibition of factor VII in a patient with AIDS. American Journal of Clinical Pathology, 91, 491-493.
45. Nojima, J., Kuratsu, H., Suehisa, E., Futsukaichi, Y., Yamanishi, J., Machii, T., Iwatani, Y. & Kanakura, Y. (2001) Association between the prevalence of antibodies to β2-glycoprotein 1, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications [see also Editorial, p. 985, by Monico Galli]. Clinical Chemistry, 47, 1008-1015.
46. Norbis, F., Galli, M., Diott, J., Short, C., Ruggeri, L., Barbui, T. & Triplett, D.A. (1999) IgG and IgM anticardioplipin, anti-β2-glycoprotein 1, and anti-prothrombin antibodies: correlation with thrombosis in lupus anticoagulant-positive patients. Thrombosis and Haemostasis, August Suppl. (Abstract 309), p. 101.
47. Pengo, V., Basiolo, A., Brocco, T., Torietto, S. & Ruffati, A. (1996) Autoantibodies to phospholipids binding plasma proteins in patients with thrombosis and phospholipid reactive antibodies. Thrombosis and Haemostasis, 75, 721-724.
48. Petri, M. (1998) Update on phospholipid antibodies. Current Opinions in Rheumatology, 10, 426-430.
49. Philippou, H., Adami, A., Amersey, R.A., Stubbs, P.J. & Lane, D.A. (1997) A novel specific immunoassay for plasma two-chain factor VIIa: investigation of FVIIa levels in normal individuals and in patients with acute coronary syndromes. Blood, 89, 767-775.
50. Puurunen, M., Vaarala, O., Julkunen, H., Aho, K. & Paluso, T. (1996) Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Clinical Immunology and Immunopathology, 80, 16-22.
51. Rand, J.H., Macik, B.G. & Konkle, B.A. (2001) Thrombophilia: What's a practitioner to do? (Diagnosis and treatment of the antiphospholipid syndrome). In: American Society of Hematology Education Program Book (ed. by G.P. Schecter, V.C. Broudy, M.E. Williams & J.L. Bajus), pp. 322-324. American Society of Hematology, Washington, DC.
52. Reber, G., Schousboe, I., Tincani, A., Sanmarco, M., Kveder, T., Moerloose, P.D., Boffa, M.C. & Arvieux, J. (2002) Inter-laboratory variability of anti-β2-glycoprotein I measurement: Collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. Thrombosis and Haemostasis, 88, 66-73.
53. Roubey, R.A.S. (1996) Immunology of the antiphospholipid antibody syndrome. Arthritis and Rheumatism, 39, 1444-1454.
54. Roubey, R.A.S., Pratt, C.W., Buyon, J.P. & Winfield, J.B. (1992) Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2-glycoprotein 1. Journal of Clinical Investigation, 90, 1100-1104.
55. Sanmarco, M., Alessi, M.C., Harle, J.R., Sapin, C., Aillaud, M.F., Gentile, S., Juhan-Vague, I. & Weiller, P.J. (2001) Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thrombosis. Thrombosis and Haemostasis, 85, 800-805.
56. Scarabin, P.Y., Vissac, A.M., Kirzin, J.M., Bourgeat, P., Amiral, J., Agher, R. & Guize, L. (1996) Population correlates of coagulation factor VII, Importance of age, sex and menopausal status as determinants of activated factor VII. Arteriosclerosis, Thrombosis and Vascular Biology, 16, 1170-1176.
57. Schulman, S., Johnsson, H. & Lindmarker, P. (1991) Thrombotic complications after substitution with a FVII concentrate (letter). Thrombosis and Haemostasis, 66, 619.
58. Simantov, R., Lo, S.K., Gharavi, A., Sammaritano, L.R., Salmon, J.E. & Silverstein, R.L. (1996) Antiphospholipid antibodies activate vascular endothelial cells. Lupus, 5, 440-441.
59. Swadzba, J., DeClerck, L.S., Stevens, W.J., Bridts, C.H., vanCotthem, K.A. & Musial, J. (1997) Anticardiolipin, anti-beta2- glycoprotein J, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. Journal of Rheumatology, 24, 1710-1715.
60. Tincani, A., Allegri, F., Sanmarco, M., Cinquini, M., Taglietti, M., Balestrieri, G., Koike, T., Ichikawa, K., Meroni, P. & Boffa, M.C. (2001) Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations. A Cooperative Project of the European Antiphospholipid Forum. Thrombosis and Haemostasis, 86, 575-583.
61. Vermylen, J., Hoylaerts, M.F. & Arnout, J. (1997) Antibody-mediated thrombosis. Thrombosis and Haemostasis, 78, 420-426.
62. Weltermann, A., Eichinger, S. & Kyrle, P.A. (1998) A novel immunoassay for the quantification of human tissue factor binding to activated factor VII. Blood Coagulation and Fibrinolysis, 9, 177-182.
63. Williams, F.M.K., Parmar, K., Hughes, G.R.V. & Hunt, B.J. (2000) Systemic endothelial cell markers in primary antiphospholipid syndrome. Thrombosis and Haemostasis, 84, 742-746.
64. Wilson, W.A., Gharavi, A.E., Koike, T., Lockshin, M.D., Branch, D.W., Piette, J.C., Brey, R., Derksen, R., Harris, E.N., Hughes, G.R.V., Triplett, D.A. & Khamashta, M.A. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis and Rheumatism, 42, 1309-1311.